Japan Gore-Tex Cleared To Market Nation’s First Stent Graft
This article was originally published in PharmAsia News
Japan's Health Ministry has given the okay to Japan Gore-Tex to market a stent graft for treating thoracic aortic aneurysms. The company plans to use its eponymous fabric to make the graft, already approved in the United States and Europe. As the first such device to be marketed in Japan, where as many as 7,000 people might benefit from it, Japan Gore-Tex plans to limit initial marketing to hospitals with surgeons and facilities capable of inserting the stents. (Click here for more - a subscription may be required
You may also be interested in...
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.